Sotac Pharmaceuticals Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '24 Sep 30, 2024	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020
Cash & Equivalents	5.21	34.18	96.82	0.28	2.69	4.28
Short-Term Investments	-	4.33	4.12	-	1.68	1.57
Cash & Short-Term Investments	5.21	38.51	100.94	0.28	4.37	5.86
Cash Growth	-64.31%	-61.85%	36470.65%	-93.68%	-25.36%	-
Accounts Receivable	281.33	262.88	147.41	122.53	58.85	69.6
Other Receivables	-	-	3.22	0.55	6.58	3.43
Receivables	281.33	262.88	150.63	123.08	65.43	73.03
Inventory	164.21	180.1	136.42	53.95	48.29	23.23
Prepaid Expenses	-	1.39	0.55	0.11	0.07	-
Other Current Assets	144.44	123.58	82.85	81.35	55.33	35.36
Total Current Assets	595.2	606.45	471.39	258.76	173.49	137.48
Property, Plant & Equipment	458.97	387.19	240.5	87.94	165.58	159.9
Long-Term Investments	61.79	20.96	-	3.92	1.29	-
Goodwill	19.06	19.01	19.06	-	-	-
Other Intangible Assets	0.24	0.13	0.03	0.05	0.01	0.01
Long-Term Deferred Tax Assets	14.52	14.27	-	0.2	-	-
Other Long-Term Assets	5.33	5.25	5.25	1.66	6.6	6.43
Total Assets	1,155	1,053	736.39	352.54	346.98	303.82
Accounts Payable	329.88	288.94	253.94	197.42	130.17	113.89
Accrued Expenses	-	6.5	9.63	4.42	3.74	1.69
Short-Term Debt	165.83	98.75	108.24	51.86	65.47	59.94
Current Portion of Long-Term Debt	-	28.53	34.46	12.31	13.03	13.03
Current Income Taxes Payable	-	3.97	15.95	-	-	-
Other Current Liabilities	34.28	10.61	35.91	10.05	15.23	4.88
Total Current Liabilities	529.99	437.3	458.12	276.05	227.63	193.42
Long-Term Debt	114.05	121.31	77.69	9.7	92.79	61.48
Long-Term Deferred Tax Liabilities	-	-	2.77	-	0.49	1.61
Other Long-Term Liabilities	-	-	-	-	-0	0
Total Liabilities	645.75	559.98	539.54	286.32	321.3	256.69
Common Stock	110.5	110.5	80.5	23	23	23
Additional Paid-In Capital	-	280.23	-	-	-	-
Retained Earnings	-	58.81	16	-	-	-
Comprehensive Income & Other	361.05	3.06	98.1	43.22	1.94	7.57
Total Common Equity	471.55	452.59	194.59	66.22	24.94	30.57
Minority Interest	37.8	40.7	2.26	-	0.74	16.56
Shareholders' Equity	509.35	493.29	196.86	66.22	25.68	47.13
Total Liabilities & Equity	1,155	1,053	736.39	352.54	346.98	303.82
Total Debt	279.88	248.59	220.39	73.88	171.28	134.44
Net Cash (Debt)	-274.66	-210.08	-119.45	-73.6	-166.91	-128.59
Net Cash Per Share	-24.85	-19.14	-14.84	-9.14	-20.73	-37.08
Filing Date Shares Outstanding	11.91	11.05	8.05	8.05	8.05	3.47
Total Common Shares Outstanding	11.91	11.05	8.05	8.05	8.05	3.47
Working Capital	65.21	169.15	13.27	-17.29	-54.13	-55.94
Book Value Per Share	39.60	40.96	24.17	8.23	3.10	8.82
Tangible Book Value	452.25	433.45	175.5	66.17	24.93	30.56
Tangible Book Value Per Share	37.98	39.23	21.80	8.22	3.10	8.81
Land	-	87.41	39.22	11.92	25.05	25.05
Buildings	-	89.61	82.7	30.2	32.71	30.54
Machinery	-	259.72	188.01	93.24	162.07	132.62
Construction In Progress	-	51.24	0.41	-	-	-

Source: S&P Capital IQ. Standard template. Financial Sources.